310 related articles for article (PubMed ID: 28822586)
1. Intravenous Mannitol Versus Placebo During Partial Nephrectomy in Patients with Normal Kidney Function: A Double-blind, Clinically-integrated, Randomized Trial.
Spaliviero M; Power NE; Murray KS; Sjoberg DD; Benfante NE; Bernstein ML; Wren J; Russo P; Coleman JA
Eur Urol; 2018 Jan; 73(1):53-59. PubMed ID: 28822586
[TBL] [Abstract][Full Text] [Related]
2. Phase III Trial of Intravenous Mannitol Versus Placebo During Nephron-sparing Surgery: Post Hoc Analysis of 3-yr Outcomes.
Wong NC; Alvim RG; Sjoberg DD; Shingarev R; Power NE; Spaliviero M; Murray KS; Benfante NE; Hakimi AA; Russo P; Coleman JA
Eur Urol Focus; 2019 Nov; 5(6):977-979. PubMed ID: 31029560
[TBL] [Abstract][Full Text] [Related]
3. Exploratory Subgroup Analyses of Renal Function and Overall Survival in European Organization for Research and Treatment of Cancer randomized trial of Nephron-sparing Surgery Versus Radical Nephrectomy.
Scosyrev E; Messing EM; Sylvester R; Van Poppel H
Eur Urol Focus; 2017 Dec; 3(6):599-605. PubMed ID: 28753863
[TBL] [Abstract][Full Text] [Related]
4. Intraoperative mannitol during robotic-assisted-laparoscopic partial nephrectomy.
Choi K; Hill S; Hale N; Phillips S; Deem S
J Robot Surg; 2019 Jun; 13(3):401-405. PubMed ID: 30171484
[TBL] [Abstract][Full Text] [Related]
5. Renal function after nephron-sparing surgery versus radical nephrectomy: results from EORTC randomized trial 30904.
Scosyrev E; Messing EM; Sylvester R; Campbell S; Van Poppel H
Eur Urol; 2014 Feb; 65(2):372-7. PubMed ID: 23850254
[TBL] [Abstract][Full Text] [Related]
6. Renoprotective Procedures with a Cold Ischemia Time of <60 min Minimize the Deterioration of Kidney Function in Open Nephron-Sparing Surgery for Renal Cell Carcinoma.
Nishida H; Yamagishi A; Yagi M; Kanno H; Kurota Y; Sakurai T; Naito S; Shibasaki T; Kawazoe H; Ichiyanagi O; Kato T; Nagaoka A; Tomita Y; Tsuchiya N
Urol Int; 2017; 99(3):283-289. PubMed ID: 28723695
[TBL] [Abstract][Full Text] [Related]
7. A Nomogram to Predict Significant Estimated Glomerular Filtration Rate Reduction After Robotic Partial Nephrectomy.
Martini A; Cumarasamy S; Beksac AT; Abaza R; Eun DD; Bhandari A; Hemal AK; Porter JR; Badani KK
Eur Urol; 2018 Dec; 74(6):833-839. PubMed ID: 30224195
[TBL] [Abstract][Full Text] [Related]
8. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
9. The natural history of renal function after surgical management of renal cell carcinoma: Results from the Canadian Kidney Cancer Information System.
Mason R; Kapoor A; Liu Z; Saarela O; Tanguay S; Jewett M; Finelli A; Lacombe L; Kawakami J; Moore R; Morash C; Black P; Rendon RA
Urol Oncol; 2016 Nov; 34(11):486.e1-486.e7. PubMed ID: 27344410
[TBL] [Abstract][Full Text] [Related]
10. Parenchymal Volumetric Assessment as a Predictive Tool to Determine Renal Function Benefit of Nephron-Sparing Surgery Compared with Radical Nephrectomy.
Liss MA; DeConde R; Caovan D; Hofler J; Gabe M; Palazzi KL; Patel ND; Lee HJ; Ideker T; Van Poppel H; Karow D; Aertsen M; Casola G; Derweesh IH
J Endourol; 2016 Jan; 30(1):114-21. PubMed ID: 26192380
[TBL] [Abstract][Full Text] [Related]
11. Intraoperative Mannitol Not Essential During Partial Nephrectomy.
Cooper CA; Shum CF; Bahler CD; Sundaram CP
J Endourol; 2018 Apr; 32(4):354-358. PubMed ID: 29216760
[TBL] [Abstract][Full Text] [Related]
12. Nephron-sparing techniques independently decrease the risk of cardiovascular events relative to radical nephrectomy in patients with a T1a-T1b renal mass and normal preoperative renal function.
Capitanio U; Terrone C; Antonelli A; Minervini A; Volpe A; Furlan M; Matloob R; Regis F; Fiori C; Porpiglia F; Di Trapani E; Zacchero M; Serni S; Salonia A; Carini M; Simeone C; Montorsi F; Bertini R
Eur Urol; 2015 Apr; 67(4):683-9. PubMed ID: 25282367
[TBL] [Abstract][Full Text] [Related]
13. Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.
Patel HD; Pierorazio PM; Johnson MH; Sharma R; Iyoha E; Allaf ME; Bass EB; Sozio SM
Clin J Am Soc Nephrol; 2017 Jul; 12(7):1057-1069. PubMed ID: 28483780
[TBL] [Abstract][Full Text] [Related]
14. Outcome of kidney function after ischaemic and zero-ischaemic laparoscopic and open nephron-sparing surgery for renal cell cancer.
Ebbing J; Menzel F; Frumento P; Miller K; Ralla B; Fuller TF; Busch J; Collins JW; Adding C; Seifert HH; Ardelt P; Wetterauer C; Westhoff T; Kempkensteffen C
BMC Nephrol; 2019 Feb; 20(1):40. PubMed ID: 30717692
[TBL] [Abstract][Full Text] [Related]
15. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies.
Mir MC; Derweesh I; Porpiglia F; Zargar H; Mottrie A; Autorino R
Eur Urol; 2017 Apr; 71(4):606-617. PubMed ID: 27614693
[TBL] [Abstract][Full Text] [Related]
16. Partial nephrectomy in two patients with known T3a tumours involving the renal vein.
Kim EH; Jain S; Benway BM; Figenshau RS
BJU Int; 2012 May; 109(9):1345-8. PubMed ID: 21883846
[TBL] [Abstract][Full Text] [Related]
17. Renal Function Recovery after Nephrectomy or Nephron-Sparing Surgery in Children with Unilateral Renal Tumor.
Cozzi DA; Ceccanti S; Cozzi F
Eur J Pediatr Surg; 2017 Feb; 27(1):74-80. PubMed ID: 27533314
[No Abstract] [Full Text] [Related]
18. End-Stage Renal Disease After Renal Surgery in Patients with Normal Preoperative Kidney Function: Balancing Surgical Strategy and Individual Disorders at Baseline.
Capitanio U; Larcher A; Terrone C; Antonelli A; Volpe A; Fiori C; Furlan M; Dehò F; Minervini A; Serni S; Porpiglia F; Trevisani F; Salonia A; Carini M; Simeone C; Montorsi F; Bertini R
Eur Urol; 2016 Oct; 70(4):558-561. PubMed ID: 27021797
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
20. Radical Versus Partial Nephrectomy for cT1 Renal Cell Carcinoma.
Gershman B; Thompson RH; Boorjian SA; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2018 Dec; 74(6):825-832. PubMed ID: 30262341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
